GENE ONLINE|News &
Opinion
Blog

Coronavirus
BIO Digital 2020 Highlights: How COVID-19 Will Radically Change Biomedical R&D Across the Globe?
2020-06-21
BIO Digital 2020 Highlights: Leveraging Platforms and Partnerships to Develop COVID-19 Vaccines in Record Time
2020-06-21
Dexamethasone Renews Hopes for a Life Saving COVID-19 Treatment
2020-06-20
FDA Revokes Emergency Authorization of Malarial Drugs for Treating COVID-19
2020-06-18
SAB Biotherapeutics Mines Cow’s Antibodies for Treating COVID-19
2020-06-17
A Secondary Route of Viral Entry Could Explain Enhanced Pathogenicity of COVID-19
2020-06-14
COVID-19 Vaccine: Novavax Gets Funding from the US Department of Defense
2020-06-09
Remdesivir Registers Middling Benefit in Patients with Moderate COVID-19
2020-06-01
ASCO 2020: Global Consortiums CCC19, and TERAVOLT Improve Understanding of Cancer and COVID-19
2020-05-31
An Old SARS Antibody May Well be Our Weapon against COVID-19
2020-05-23
COVID-19: AstraZeneca Receives $1B from BARDA to Develop Oxford’s Coronavirus Vaccine
2020-05-23
Links Between COVID-19 and Coagulopathy – A New Direction for COVID-19 Research
2020-05-22
COVID-19: Moderna Registers Positive Phase 1 Results for mRNA Vaccine
2020-05-18
A Review of Neurological Symptoms in COVID-19 Patients
2020-05-18
ACE2: A Valuable Biomarker for COVID19 Susceptibility in Heart Patients
2020-05-16
1 7 8 9 10 11 13
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top